HomeDYN • NASDAQ
Follow
Dyne Therapeutics Inc
Previous close
$26.78
Day range
$26.81 - $29.80
Year range
$6.40 - $30.27
Market cap
2.34B USD
Avg Volume
1.63M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 67.69M | 68.61% |
Net income | -66.64M | -71.63% |
Net profit margin | — | — |
Earnings per share | -1.09 | -47.30% |
EBITDA | -67.29M | -69.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 123.10M | -51.92% |
Total assets | 165.08M | -46.11% |
Total liabilities | 73.79M | 36.75% |
Total equity | 91.29M | — |
Shares outstanding | 81.96M | — |
Price to book | 17.97 | — |
Return on assets | -91.39% | — |
Return on capital | -113.20% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -66.64M | -71.63% |
Cash from operations | -35.01M | -19.92% |
Cash from investing | 26.20M | 36.18% |
Cash from financing | 147.00K | -99.60% |
Net change in cash | -8.66M | -131.79% |
Free cash flow | -10.74M | 33.41% |
About
Founded
2017
Headquarters
Website
Employees
141